What The Study Did:
This study describes changes in list and net prices for 600 branded drugs in the U.S. from 2007 to 2018 and estimated the extent to which price increases were offset by increases in discounts. This study is part of a theme issue from JAMA on drug pricing.
Authors:
Inmaculada Hernandez, Pharm.D., Ph.D. of the University of Pittsburgh School of Pharmacy, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https:/
/
media.
jamanetwork.
com/
(doi:10.1001/jama.2020.1012)
Editor’s Note:
The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
###
Media advisory:
The full study and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
https:/
/
jamanetwork.
com/
journals/
jama/
fullarticle/
10.
1001/
jama.
2020.
1012?guestAccessKey=
436c5e49-870b-46ae-b1f5-250603900c85&utm_source=
For_The_Media&utm_medium=
referral&utm_campaign=
ftm_links&utm_content=
tfl&utm_term=
030320
This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-03/jn-cid022820.php
